<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To observe the expressions of CD10 in childhood B-<z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>) and to define the role of CD10 in <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e>) detection </plain></SENT>
<SENT sid="1" pm="."><plain>58 cases of childhood <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> were studied in this program </plain></SENT>
<SENT sid="2" pm="."><plain>Four-color flow cytometry was used to analyze the characteristics of <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> phenotypes </plain></SENT>
<SENT sid="3" pm="."><plain>The four-color <z:chebi fb="1" ids="51217">fluorochrome</z:chebi> labeled antibody combinations of CD10 with other markers were used to detect <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The results showed that CD10 overexpression (CD10(bright)) was detected in 65.5% (38/58) of <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> patients and a strong correlation between CD10(bright) and CD34 expression was also observed, i.e. CD10(bright) expression most frequently happened in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> with high percentage of CD34 positive cells </plain></SENT>
<SENT sid="5" pm="."><plain>In detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e>, CD10(bright), combined with other markers, could effectively distinguish <z:mpath ids='MPATH_458'>normal</z:mpath> cells with leukemic cells, even if there was no any other marker that can be used </plain></SENT>
<SENT sid="6" pm="."><plain>It is concluded that CD10(bright) expression correlates with high expression of CD34 in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, it is a good marker for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> detection </plain></SENT>
<SENT sid="7" pm="."><plain>The combination of CD10 and other markers can be applied in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> detection with flow cytometry </plain></SENT>
</text></document>